First data from phase 1b/2 EPCORE NHL-4: Epcoritamab (Epcor) in Chinese patients (Pts) with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL).

Authors: Weili Zhao, Haiyan Yang, Huiqiang Huang, Liling Zhang, Jie Jin, Wenyu Li, Hongmei Jing, Fei Li, Shiyong Zhou, Tingbo Liu, Yufu Li, Caixia Li, Liqun Zou, Signe Diness Vindeloev, Tingyu Yin, Xin Chen, Charlotte Moureaud, Tony Jiang

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e19001

Source: Full article

---

Abstract

e19001